A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis

Clinical trial NCT02473393 · COMPLETED

Trial details

NCT number: NCT02473393
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bacterial Enteritis

Start date: 2015-08-20
Primary completion: 2017-03-14
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.